Skip to content

Examining the role of serum periostin as a prognostic marker of asthma

Examining the role of serum periostin as a prognostic marker of asthma - test for serum periostin as a prognostic marker of asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030674
Enrollment
217
Registered
2018-01-11
Start date
2018-01-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were enrolled in KiHAC multicenter study

Exclusion criteria

Exclusion criteria: Patients who expressed a denial of secondary use to other research.

Design outcomes

Primary

MeasureTime frame
Associations between baseline serum periostin levels and 1) later treatment steps including the use of biologics 2) follow-up ratio and asthma control

Countries

Japan

Contacts

Public ContactHisako Hisako Matsumoto

Kyoto University Respiratory Medicine

hmatsumo@kuhp.kyoto-u.ac.jp075-751-3830

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026